Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Industry Braces For Supreme Court Ruling In Wyeth Pre-emption Case

This article was originally published in The Tan Sheet

Executive Summary

This week everyone's attention is riveted on the presidential election. But for the pharmaceutical industry there is another issue just as compelling. On Nov. 3, the U.S. Supreme Court will hear oral arguments in the case that will decide the future of product liability litigation

You may also be interested in...



Supreme Court Ruling In Wyeth Case May Make FDA More Cautious

How the U.S. Supreme Court rules in Wyeth v. Levine could limit the number of product liability suits brought against drug companies

Supreme Court Ruling In Wyeth Case May Make FDA More Cautious

How the U.S. Supreme Court rules in Wyeth v. Levine could limit the number of product liability suits brought against drug companies

Supreme Court Ruling In Wyeth Case May Make FDA More Cautious

How the U.S. Supreme Court rules in Wyeth v. Levine could limit the number of product liability suits brought against drug companies

Related Content

Topics

UsernamePublicRestriction

Register

OM001644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel